Gemma Modinos1,2, Alice Egerton1, Anna McLaughlin1, Katrina McMullen2, Veena Kumari3, David J Lythgoe2, Gareth J Barker2, André Aleman4, Steve C R Williams2. 1. Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. 2. Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. 3. Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. 4. Department of Neuroscience, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: Cortical glutamatergic dysfunction is thought to be fundamental for psychosis development, and may lead to structural degeneration through excitotoxicity. Glutamate levels have been related to gray matter volume (GMV) alterations in people at ultra-high risk of psychosis, and we previously reported GMV changes in individuals with high schizotypy (HS), which refers to the expression of schizophrenia-like characteristics in healthy people. This study sought to examine whether GMV changes in HS subjects are related to glutamate levels. METHODS: We selected 22 healthy subjects with HS and 23 healthy subjects with low schizotypy (LS) based on their rating on a self-report questionnaire for psychotic-like experiences. Glutamate levels were measured in the bilateral anterior cingulate cortex (ACC) using proton magnetic resonance spectroscopy, and GMV was assessed using voxel-based morphometry. RESULTS: Subjects with HS showed GMV decreases in the rolandic operculum/superior temporal gyrus (pFWE = 0.045). Significant increases in GMV were also detected in HS, in the precuneus (pFWE = 0.043), thereby replicating our previous finding in a separate cohort, as well as in the ACC (pFWE = 0.041). While the HS and LS groups did not differ in ACC glutamate levels, in HS subjects ACC glutamate was negatively correlated with ACC GMV (pFWE = 0.026). Such association was absent in LS. CONCLUSIONS: Our study shows that GMV findings in schizotypy are related to glutamate levels, supporting the hypothesis that glutamatergic function may lead to structural changes associated with the expression of psychotic-like experiences.
BACKGROUND: Cortical glutamatergic dysfunction is thought to be fundamental for psychosis development, and may lead to structural degeneration through excitotoxicity. Glutamate levels have been related to gray matter volume (GMV) alterations in people at ultra-high risk of psychosis, and we previously reported GMV changes in individuals with high schizotypy (HS), which refers to the expression of schizophrenia-like characteristics in healthy people. This study sought to examine whether GMV changes in HS subjects are related to glutamate levels. METHODS: We selected 22 healthy subjects with HS and 23 healthy subjects with low schizotypy (LS) based on their rating on a self-report questionnaire for psychotic-like experiences. Glutamate levels were measured in the bilateral anterior cingulate cortex (ACC) using proton magnetic resonance spectroscopy, and GMV was assessed using voxel-based morphometry. RESULTS: Subjects with HS showed GMV decreases in the rolandic operculum/superior temporal gyrus (pFWE = 0.045). Significant increases in GMV were also detected in HS, in the precuneus (pFWE = 0.043), thereby replicating our previous finding in a separate cohort, as well as in the ACC (pFWE = 0.041). While the HS and LS groups did not differ in ACC glutamate levels, in HS subjects ACC glutamate was negatively correlated with ACC GMV (pFWE = 0.026). Such association was absent in LS. CONCLUSIONS: Our study shows that GMV findings in schizotypy are related to glutamate levels, supporting the hypothesis that glutamatergic function may lead to structural changes associated with the expression of psychotic-like experiences.
Authors: P Fusar-Poli; S Borgwardt; A Crescini; G Deste; Matthew J Kempton; S Lawrie; P Mc Guire; E Sacchetti Journal: Neurosci Biobehav Rev Date: 2010-12-17 Impact factor: 8.989
Authors: Preethi Premkumar; Ulrich Ettinger; Sophie Inchley-Mort; Alexander Sumich; Steven C R Williams; Elizabeth Kuipers; Veena Kumari Journal: Hum Brain Mapp Date: 2011-03-21 Impact factor: 5.038
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Elias Mouchlianitis; Michael A P Bloomfield; Vincent Law; Katherine Beck; Sudhakar Selvaraj; Naresh Rasquinha; Adam Waldman; Federico E Turkheimer; Alice Egerton; James Stone; Oliver D Howes Journal: Schizophr Bull Date: 2015-12-17 Impact factor: 9.306
Authors: Katharina O Sandström; Olga B Baltzersen; Anouk Marsman; Cecilie K Lemvigh; Vincent O Boer; Kirsten B Bojesen; Mette Ø Nielsen; Henrik Lundell; Daban K Sulaiman; Mikkel E Sørensen; Birgitte Fagerlund; Adrienne C Lahti; Warda T Syeda; Christos Pantelis; Esben T Petersen; Birte Y Glenthøj; Hartwig R Siebner; Bjørn H Ebdrup Journal: Front Psychiatry Date: 2022-05-20 Impact factor: 5.435
Authors: Gemma Modinos; Alice Egerton; Katrina McMullen; Anna McLaughlin; Veena Kumari; Gareth J Barker; Steve C R Williams; Fernando Zelaya Journal: Hum Brain Mapp Date: 2018-06-08 Impact factor: 5.038
Authors: Fanni Krajner; Laila Hadaya; Grant McQueen; Kyra-Verena Sendt; Amy Gillespie; Alessia Avila; John Lally; Emily P Hedges; Kelly Diederen; Oliver D Howes; Gareth J Barker; David J Lythgoe; Matthew J Kempton; Philip McGuire; James H MacCabe; Alice Egerton Journal: Schizophrenia (Heidelb) Date: 2022-03-02
Authors: Matthias Kirschner; Benazir Hodzic-Santor; Mathilde Antoniades; Igor Nenadic; Tilo Kircher; Axel Krug; Tina Meller; Dominik Grotegerd; Alex Fornito; Aurina Arnatkeviciute; Mark A Bellgrove; Jeggan Tiego; Udo Dannlowski; Katharina Koch; Carina Hülsmann; Harald Kugel; Verena Enneking; Melissa Klug; Elisabeth J Leehr; Joscha Böhnlein; Marius Gruber; David Mehler; Pamela DeRosse; Ashley Moyett; Bernhard T Baune; Melissa Green; Yann Quidé; Christos Pantelis; Raymond Chan; Yi Wang; Ulrich Ettinger; Martin Debbané; Melodie Derome; Christian Gaser; Bianca Besteher; Kelly Diederen; Tom J Spencer; Paul Fletcher; Wulf Rössler; Lukasz Smigielski; Veena Kumari; Preethi Premkumar; Haeme R P Park; Kristina Wiebels; Imke Lemmers-Jansen; James Gilleen; Paul Allen; Petya Kozhuharova; Jan-Bernard Marsman; Irina Lebedeva; Alexander Tomyshev; Anna Mukhorina; Stefan Kaiser; Anne-Kathrin Fett; Iris Sommer; Sanne Schuite-Koops; Casey Paquola; Sara Larivière; Boris Bernhardt; Alain Dagher; Phillip Grant; Theo G M van Erp; Jessica A Turner; Paul M Thompson; André Aleman; Gemma Modinos Journal: Mol Psychiatry Date: 2021-10-27 Impact factor: 13.437